PUBLISHED: MAR 2019

Canada In-vitro Diagnostics Market - Growth, Trends, and Forecast (2019-2024)

The market is segmented by Technique, Product, Usability, Application, and End Users

Market Snapshot

Canada In-vitro Diagnostics Market

Study Period:

2016-2024

Base Year:

2018

Fastest Growing Market:

Asia Pacific

Largest Market:

North America

Key Players:

PURCHASE REPORT

Market Overview

Canada in-vitro diagnostics market is expected to register a CAGR of 5.2% over the forecast period. And the few factors that are responsible for the growth of this market include increasing use of Point-of-care (POC) diagnostics, advanced technologies, and increasing awareness and acceptance of personalized medicine and companion diagnostics.

IVDs are extremely valuable for disease prevention, detection, and management. They have the ability to influence almost two-thirds of clinical decision making while accounting for just 2% of healthcare spending. The emerging technological innovations in healthcare, such as bio-sensors, lab-on-a-chip, wearable devices, and POC diagnostics, are increasingly becoming an important part of the healthcare landscape. POC diagnostics are no longer limited to simple tests, and can now be used for diagnosing serious conditions. For example, the POC test for Prostate-specific Antigen (PSA) is used for the diagnosis of prostate cancer in men. Similarly, several POC diagnostic products have been developed to be used on a patient’s bed-side in hospitals, to get instant results without the need of sending the samples to the lab. Owing to the ease of use and ability to provide instant results, combined with ease of procurement, the use of POC diagnostics in the Canada is increasing rapidly, and this, in turn, is promoting the growth of the IVD market in the country.

Scope of the Report

In-vitro diagnostics involves medical devices and consumables that are utilized to perform in vitro tests on various biological samples. They are used for the diagnosis of various medical conditions, such as chronic diseases.

By Technique
Immunochemistry
POC Diagnostics
Molecular Diagnostics
Hematology
Tissue Diagnostics
Microbiology
Self-blood Glucose Monitoring
Others
By Product
Instrument
Reagent
Data Management System
By Usability
Disposable IVD Devices
Reusable IVD Devices
By Application
Infectious Disease
Diabetes
Cancer/Oncology
Cardiology
Autoimmune Disease
Nephrology
Drug Testing
HIV/AIDS
Others
By End Users
Laboratory
Hospital
Others

Key Market Trends

Infectious Disease is Expected to Hold the Highest Revenue Share in the Application Segment

Infectious disease segment holds the major revenue share in the IVD application due to the presence of a high number of infectious disease cases. As per the World Health Organization, nearly 17 million deaths are caused each year by infectious diseases. They account for nearly 30% of the annual mortality rate, worldwide. And for certain infectious diseases like influenza, the point-of-care is well established across the developed markets, such as the Canada. For infectious diseases identification, molecular diagnostics, including microarray analysis, mass spectrometry, and nucleic acid amplification, is the fastest-growing segment. A large number of companies are investing for opportunistic growth in essential IVD list (EDL) by WHO, including syphilis and human papillomavirus infections. Several large companies have welcomed the EDL list of 2018 by the WHO, such as Qiagen and Thermo Fisher Scientific. These companies have technology advanced testing products for a range of infectious diseases. All these factors are helping to grow positively over the forecast period.

Canada In-vitro Diagnostics Market

Competitive Landscape

The canada In-vitro diagnostics market is moderately competitive and consists of several major players. In terms of market share, few of the major players currently dominate the market. And With the rising need for diagnostics due to the rising prevelance of diaseases and the advances in IVD, is helping the few other smaller players for entering the market. Some of the major players of the market are Becton Dickinson and Company, Biomerieux, Biorad Laboratories Inc., Danaher Corporation, and Thermo Fisher Scientific among others.

Major Players

  1. Becton Dickinson and Company
  2. Biomerieux
  3. Biorad Laboratories Inc.
  4. Danaher Corporation
  5. Thermo Fisher Scientific

* Complete list of players covered available in the table of contents below

Canada In-vitro Diagnostics Market

Customize the Report

80% of our clients ask for some sort of customisation, be it specific countries / companies / segments.

What are you looking for?

Please Enter a Valid Message!

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increasing Use of Point-of-care (POC) Diagnostics

      2. 4.2.2 Advanced Technologies

      3. 4.2.3 Increasing Awareness and Acceptance of Personalized Medicine and Companion Diagnostics

    3. 4.3 Market Restraints

      1. 4.3.1 Stringent Regulations

      2. 4.3.2 Cumbersome Reimbursement Procedures

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Technique

      1. 5.1.1 Immunochemistry

      2. 5.1.2 POC Diagnostics

      3. 5.1.3 Molecular Diagnostics

      4. 5.1.4 Hematology

      5. 5.1.5 Tissue Diagnostics

      6. 5.1.6 Microbiology

      7. 5.1.7 Self-blood Glucose Monitoring

      8. 5.1.8 Others

    2. 5.2 By Product

      1. 5.2.1 Instrument

      2. 5.2.2 Reagent

      3. 5.2.3 Data Management System

    3. 5.3 By Usability

      1. 5.3.1 Disposable IVD Devices

      2. 5.3.2 Reusable IVD Devices

    4. 5.4 By Application

      1. 5.4.1 Infectious Disease

      2. 5.4.2 Diabetes

      3. 5.4.3 Cancer/Oncology

      4. 5.4.4 Cardiology

      5. 5.4.5 Autoimmune Disease

      6. 5.4.6 Nephrology

      7. 5.4.7 Drug Testing

      8. 5.4.8 HIV/AIDS

      9. 5.4.9 Others

    5. 5.5 By End Users

      1. 5.5.1 Laboratory

      2. 5.5.2 Hospital

      3. 5.5.3 Others

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 BioMerieux

      2. 6.1.2 Danaher Corporation

      3. 6.1.3 F. Hoffmann-La Roche AG

      4. 6.1.4 Becton, Dickinson and Company

      5. 6.1.5 Bio-Rad Laboratories Inc.

      6. 6.1.6 Abbott Laboratories

      7. 6.1.7 Arkray Inc.

      8. 6.1.8 Hologic

      9. 6.1.9 Thermo Fischer Scientific Inc.

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments

Complete your payment details below

Shipping & Billing Information

Payment Information